Cargando…
Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404178/ https://www.ncbi.nlm.nih.gov/pubmed/34462541 http://dx.doi.org/10.1038/s41598-021-97281-9 |
| _version_ | 1783746118092324864 |
|---|---|
| author | Vagapova, Elmira R. Lebedev, Timofey D. Prassolov, Vladimir S. |
| author_facet | Vagapova, Elmira R. Lebedev, Timofey D. Prassolov, Vladimir S. |
| author_sort | Vagapova, Elmira R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8404178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84041782021-08-30 Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis Vagapova, Elmira R. Lebedev, Timofey D. Prassolov, Vladimir S. Sci Rep Publisher Correction Nature Publishing Group UK 2021-08-30 /pmc/articles/PMC8404178/ /pubmed/34462541 http://dx.doi.org/10.1038/s41598-021-97281-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Vagapova, Elmira R. Lebedev, Timofey D. Prassolov, Vladimir S. Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title | Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title_full | Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title_fullStr | Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title_full_unstemmed | Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title_short | Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis |
| title_sort | publisher correction: viral fibrotic scoring and drug screen based on mapk activity uncovers egfr as a key regulator of covid-19 fibrosis |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404178/ https://www.ncbi.nlm.nih.gov/pubmed/34462541 http://dx.doi.org/10.1038/s41598-021-97281-9 |
| work_keys_str_mv | AT vagapovaelmirar publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis AT lebedevtimofeyd publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis AT prassolovvladimirs publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis |